Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Pfizer claims endothelin ETA antagonists for cardiovascular disorders

May 22, 2002

Selective inhibition of PDGF-B prevents vascular remodeling in perinatal pulmonary hypertension

May 21, 2002

Chinese patients respond well to VEGF-based gene therapy for critical limb ischemia

May 21, 2002

p38 MAPK inhibitor exerts beneficial effects following myocardial infarction in rats

May 21, 2002

First trial of FGF-1 gene therapy in critical limb ischemia yields positive results

May 21, 2002

Mimotopes and Baker Medical Research Institute to develop novel cardiovascular drugs

May 17, 2002

Endothelin receptor antagonists identified at Actelion

May 16, 2002

SPP-301 enters phase II testing

May 15, 2002

AGI-1096 decreases preclinical graft narrowing associated with transplant rejection

May 15, 2002

NCX-4016 inhibits vascular inflammation and platelet activation in phase I/IIa study

May 14, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...